Tri-Institutional Therapeutics Discovery Institute expands focus to include antibody drug discovery research

Thursday, June 16, 2016 - 17:10 in Health & Medicine

The Tri-I TDI, a partnership established in 2013 to expedite early-stage drug discovery of innovative new small molecule therapies, announced today that it will expand its scope to support the development of antibody drug discovery. More »

Read the whole article on The Rockefeller University

More from The Rockefeller University

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net